ISRCTN01332857已完成未知
Study Into the Effect of Pamidronate for the Prevention of Heterotopic Ossification in High-Risk Patients: A Randomized Controlled Trial
niversity Hospital of Basel (Switzerland)0 个研究点目标入组 40 人开始时间: 2006年3月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Consecutive patients with established HO (Brooker grade III-IV), hospitalized for resection of HO lesions
排除标准
- •1. Age <20 years
- •2. Vitamin D deficiency (25OH vitamin D <30 ng/ml)
- •3. Renal insufficiency (clearance <50 ml/min)
- •4. Intolerance of bisphosphonates
- •5. Unable to provide informed consent
研究者
相似试验
已完成
2 期
Treatment of thalassemia-induced osteoporosis with pamidronateThalassemia.Beta thalassemiaD56.1IRCT20211008052698N1Oroumia University of Medical Sciences20
已完成
2 期
Evaluation of the Effect of Amiodarone on Prevention of Arrhythmias in Patients underwent Coronary Artery Bypass Graft Surgerycoronary arthery heart disease.Atherosclerotic heart diseaseIRCT2016053014372N7Shiraz University of Medical Sciences60
已完成
不适用
Pamidronate and disease activity in rheumatoid arthritisRheumatoid arthritis.Seropositive rheumatoid arthritisIRCT138801051778N1Vice chancellery of research37
已完成
2 期
Effect of amiodarone in postoperative atrial fibrillation after coronary artery bypass surgeryIRCT2014090813156N7Research Centre of Mazandaran Univeristy of Medical Sciences150
已完成
3 期
Efficacy of Oral Amiodarone in atrial fibrillation after open heart surgeryIRCT20151109024975N8Sari University of Medical Sciences400